Insight Genetics Announces Promotions for Two Team Members
News Aug 21, 2014
Insight Genetics researches, develops and commercializes diagnostic tests that guide physicians in their diagnoses, treatment selections, and resistance monitoring for specific populations of cancer patients. Insight Genetics has recently expanded its R&D team to include 6 new members.
“Kasey and Tyler have been great additions to the Insight Genetics team,” said Christopher Callaghan, President and COO of Insight Genetics. “They have played integral roles in our laboratory operations and contributed significantly to our development of companion diagnostics in cancer. We are pleased to recognize their work and promote them to new roles within our company.”
As Research Scientist, Tyler Nielsen will coordinate projects and manage resources in Insight Genetics’ research laboratory for the development of companion diagnostics. Nielsen brings extensive knowledge and skills in molecular diagnostic procedures, concepts and practices to his scientific team. Prior to this new role, Nielsen was a Research Associate III. He received his M.A. in biomedical science from Des Moines University.
Kasey Lawrence, Senior Technology Specialist, is responsible for organizing and overseeing day-to-day operations of Insight Genetics’ Next Generation Sequencing program. Previously, Lawrence was a Research Associate III. He holds a bachelor of science in biology from Tennessee Tech University.
Protein Discovery Could Lead to Better Diagnosis of StressNews
Researchers have found a protein that is present in people while they are in stressful situations. The discovery could lead to identifying new ways to predict, diagnose and treat stress.READ MORE
Potential Barcode Identified for a Form of Alcoholic Liver DiseaseNews
NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.READ MORE
Enterome and Nestlé Health Sciences Launch New Diagnostics CompanyNews
Enterome and Nestlé Health Sciences join to create Microbiome Diagnostics Partners, a company that will enable the development and diagnostics for multiple diseases including inflammatory bowel diseases (IBD) and liver diseases.READ MORE